Finland · How much has Aurealis Therapeutics raised?
Aurealis Therapeutics has raised $9.0M across 1 round since 2024.
Finland · Venture startup
Who invested in Aurealis Therapeutics
One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Aurealis Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$9.0Mraised across 1 round since 2024, from 1 source
- Latest round
- Venture, $9.0MNov 2024
- Investors
- 0
The rounds
- Nov 2024Venture$9.0M
No investor was named in the report.
Source recorded
Founders and team
From Aurealis Therapeutics's own website: 12 on the team.
- Juha YrjänheikkiCEO
- Hanna P. LeschCTO
- Laurent DécoryCOO
- Hanna-Riikka KärkkäinenDirector of Quality & Regulatory Affairs
- Jean De GunzburgBoard Director
- Jere KurkipuroSenior Director R&D Operations
- Maija RusiFinancial & Administrative Director
- Matleena PiiroinenSenior Drug Safety Officer
- Mirka SanioClinical Operations Director
- Roger MeierChairman of the
- Silvio InderbitzinBoard Director
- Tuomo PätsiBoard Director
AdvisersAlberto PiaggesiDavid ArmstrongKirsi Isoherranen
Quick answers about Aurealis Therapeutics
When did Aurealis Therapeutics last raise?
Aurealis Therapeutics's most recent round was a Venture of $9.0M in Nov 2024.
What was Aurealis Therapeutics's biggest round?
Its most recent round, $9.0M in Nov 2024, is also its largest on record.
What stage is Aurealis Therapeutics at?
Aurealis Therapeutics's latest named round is a Venture, in Nov 2024.
Where is Aurealis Therapeutics based?
Aurealis Therapeutics is based in Finland.
Companies like Aurealis Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.